In other clinical cohorts, elevated serum concentrations of IL-1α/IL-1β have been detected in pretreatment samples from NPC patients compared with healthy control samples, and Al-Kholy et al. The gene discussed is IL1B; the disease is nasopharyngeal carcinoma.